Singapore, May 11 -- US-based Taimei Technology, a leading artificial intelligence (AI)-powered drug clinical development platform company, and C&R Research, a top-tier CRO in South Korea, have signed an enterprise-level strategic partnership agreement for launching the development of an AI-based clinical trial operations system.

Under this partnership, C&R Research will deploy Taimei Technology's leading digital infrastructure and AI Agents across multiple clinical trials to automate and enhance trial design and operational workflows.

A particular focus will be on data management, where the EDC + iDM Agent combination will be actively adopted. Innovations such as intelligent data capture and governance, AI-driven eCRF generation, and a...